Anti-Corrosion and Adhesion Anodic Coating Technology - Licensing opportunity from Dublin Institute of Technology - December 2015 front page preview

Anti-Corrosion and Adhesion Anodic Coating Technology - Licensing opportunity from Dublin Institute of Technology - December 2015

This technology represents a novel anodising process that has been designed for the coating of metal components in aerospace, automotive, electronics and outdoor architectural applications. Anodising is an electrolytic p...

pdf 1.9MB

Identification of the relative risk of thrombosis as an aid for the selection of anti-platelet therapy - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Identification of the relative risk of thrombosis as an aid for the selection of anti-platelet therapy - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

Atherosclerotic plaque rupture followed by intravascular thrombosis is the final common pathway leading to the majority of heart attacks and strokes. While anti-platelet therapies, such as aspirin, do reduce the likeliho...

pdf 254.7KB

Breast Cancer Biomarkers as a Clinical Management Tool - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Breast Cancer Biomarkers as a Clinical Management Tool - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

Currently women diagnosed with breast cancer generally undergo surgery to remove the tumour. Many will also receive either chemo or radiotherapy or a combination of both. Approximately two thirds of all breast cancers ...

pdf 375.9KB

Novel companion diagnostic and  treatment for metastic breast cancer disease - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Novel companion diagnostic and treatment for metastic breast cancer disease - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

Endocrine therapies are the treatment of choice for over 70% of breast cancer patients, however 40% will relapse and develop metastatic disease. Metastasis is the prime cause of cancer patient mortality. There is curren...

pdf 383.4KB

Osteoporotic Bone Manipulating Device - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015 front page preview

Osteoporotic Bone Manipulating Device - Licensing Opportunity from Royal College of Surgeons in Ireland - November 2015

A multi-disciplinary team of orthopaedic surgeons and engineers at the Royal College of Surgeons in Ireland have developed, patented and clinically tested a new Osteoporotic Bone Manipulator device that protects weak ost...

pdf 219.5KB